glp 1 uk Most adults stop GLP1 therapy within a year

ReducedFrequency GLP1 Therapy Maintains Weight, Body Composition, and Metabolic Syndrome Improvements: A Case Series Wong Obesity Wiley Online Library Ozempic Lawsuit: June 2026 Blindness and Gastroparesis Claims 82% of people regain the weight within a year of stopping GLP 1 medications. Your hunger rebounds harder, your metabolism has already adapted, and there's no standard plan to come off. The research Foundayo (orforglipron) First Oral Non Peptide GLP 1 RA FDA approved April 2026 for chronic weight management. Once daily tablet with no fasting requirement, stepwise dosing up to 17.2 mg, and meaningful weight reduction in